ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
BLA Submitted to FDA for Subcutaneous Formulation of DARZALEX® Utilizing ENHANZE®
July 16, 2019Halozyme Therapeutics announced that its collaborator Janssen Biotech has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for ... -
FDA Approves Subcutaneous Formulation of Actemra for use in Active Polyarticular Juvenile Idiopathic Arthritis
May 17, 2018Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved the subcutaneous (SC) formulation of Actemra® (tocilizumab)
Pharma Sources Insight January 2025
